We found that HOXC8 contributed to NSCLC cell proliferation, anchorage-independent and migration via regulating TGF-β1 expression, and high expression of HOXC8 was associated with aggressive phenotypes and poor relapse free survival for lung cancer patients. Here, HOXC8 is linked to non-small cell lung carcinoma.